NCT04182425View on ClinicalTrials.gov

Incidence of Allergic Manifestations and Infectious Episodes in Healthy Term Infants at Risk for Dysbiosis

CompletedOBSERVATIONAL

Enrollment

334

Participants

Timeline

Start Date

December 7, 2019

Primary Completion Date

July 4, 2022

Study Completion Date

July 4, 2022

Conditions

Dermatitis, Allergic ContactInfectious Diseases

Interventions

OTHER

Infant formula

Healthy full-term infants fed on an infant formula marketed on the French market

Trial Locations (1)

Unknown

Medical Office, Taverny

All Listed Sponsors

lead

Bledina

INDUSTRY

NCT04182425 - Incidence of Allergic Manifestations and Infectious Episodes in Healthy Term Infants at Risk for Dysbiosis | Biotech Hunter | Biotech Hunter